MétaCan
Menu
Back to cohort
Record W4394961389 · doi:10.3389/fimmu.2024.1361891

Association between pre-biologic T2-biomarker combinations and response to biologics in patients with severe asthma

2024· article· en· W4394961389 on OpenAlexaff
Celeste Porsbjerg, John Townend, Céline Bergeron, George Christoff, Gregory Katsoulotos, Désirée Larenas‐Linnemann, Trung N. Tran, Riyad Al‐Lehebi, Sinthia Bosnic‐Anticevich, John Busby, Mark Hew, Κonstantinos Κostikas, Nikolaos G. Papadopoulos, Paul Pfeffer, Todor A. Popov, Chin Kook Rhee, Mohsen Sadatsafavi, Ming‐Ju Tsai, Charlotte Suppli Ulrik, Mona Al‐Ahmad, Alan Altraja, Aaron Beastall, Lakmini Bulathsinhala, Victoria Carter, Borja G. Cosío, Kirsty Fletton, Susanne Hansen, Liam G. Heaney, Richard Hubbard, Piotr Kuna, Ruth Murray, Tatsuya Nagano, Laura Pini, Diana Jimena Cano Rosales, Florence Schleich, Michael E. Wechsler, Rita Amaral, Arnaud Bourdin, Guy Brusselle, Wenjia Chen, Li Ping Chung, Eve Denton, João Fonseca, Flavia Hoyte, David J. Jackson, Rohit Katial, Bruce Kirenga, Mariko Siyue Koh, Agnieszka Ławkiedraj, Lauri Lehtimäki, Mei Fong Liew, Bassam Mahboub, Neil Martin, Andrew Menzies‐Gow, Pee Hwee Pang, Andriana Ι. Papaioannou, Pujan H. Patel, Luis Pérez de Llano, Matthew Peters, L Ricciardi, Bellanid Rodríguez-Cáceres, Iván Solarte, Tunn Ren Tay, Carlos A. Torres‐Duque, Eileen Wang, Martina Zappa, John Abisheganaden, Karin Dahl Assing, Richard W. Costello, Peter G. Gibson, Enrico Heffler, Jorge Máspero, Stefania Nicola, Diahn‐Warng Perng, Francesca Puggioni, Sundeep Salvi, Chau‐Chyun Sheu, Concetta Sirena, Camille Taillé, Tze Lee Tan, Leif Bjermer, Giorgio Walter Canonica, Takashi Iwanaga, Libardo Jiménez-Maldonado, Christian Taube, Luisa Brussino, David Price

Bibliographic record

VenueFrontiers in Immunology · 2024
Typearticle
Languageen
FieldMedicine
TopicAsthma and respiratory diseases
Canadian institutionsVancouver General HospitalUniversity of British Columbia
FundersSanofi GenzymeSeqirusShionogiGlenmark PharmaceuticalsKuwait Foundation for the Advancement of SciencesGenentechHorizon TherapeuticsCelltrionPfizerIncyteRegeneron PharmaceuticalsMylanGrifolsCerecorBristol-Myers SquibbSingapore General HospitalSanofiMundipharma InternationalCovis PharmaEli Lilly and CompanyAstraZenecaNovartis Pharmaceuticals UK LimitedCSL BehringInsmedUnited Therapeutics CorporationMedical Research CouncilTeva Pharmaceutical IndustriesDaiichi Sankyo EuropeGilead SciencesOrient EuropharmaGlaxoSmithKlineAmgen
KeywordsMedicineAsthmaAssociation (psychology)Inflammatory responseImmunologyPsychologyInflammation

Abstract

fetched live from OpenAlex

Background To date, studies investigating the association between pre-biologic biomarker levels and post-biologic outcomes have been limited to single biomarkers and assessment of biologic efficacy from structured clinical trials. Aim To elucidate the associations of pre-biologic individual biomarker levels or their combinations with pre-to-post biologic changes in asthma outcomes in real-life. Methods This was a registry-based, cohort study using data from 23 countries, which shared data with the International Severe Asthma Registry (May 2017-February 2023). The investigated biomarkers (highest pre-biologic levels) were immunoglobulin E (IgE), blood eosinophil count (BEC) and fractional exhaled nitric oxide (FeNO). Pre- to approximately 12-month post-biologic change for each of three asthma outcome domains (i.e. exacerbation rate, symptom control and lung function), and the association of this change with pre-biologic biomarkers was investigated for individual and combined biomarkers. Results Overall, 3751 patients initiated biologics and were included in the analysis. No association was found between pre-biologic BEC and pre-to-post biologic change in exacerbation rate for any biologic class. However, higher pre-biologic BEC and FeNO were both associated with greater post-biologic improvement in FEV1 for both anti-IgE and anti-IL5/5R, with a trend for anti-IL4Rα. Mean FEV1 improved by 27-178 mL post-anti-IgE as pre-biologic BEC increased (250 to 1000 cells/µL), and by 43-216 mL and 129-250 mL post-anti-IL5/5R and -anti-IL4Rα, respectively along the same BEC gradient. Corresponding improvements along a FeNO gradient (25-100 ppb) were 41-274 mL, 69-207 mL and 148-224 mL for anti-IgE, anti-IL5/5R, and anti-IL4Rα, respectively. Higher baseline BEC was also associated with lower probability of uncontrolled asthma (OR 0.392; p=0.001) post-biologic for anti-IL5/5R. Pre-biologic IgE was a poor predictor of subsequent pre-to-post-biologic change for all outcomes assessed for all biologics. The combination of BEC + FeNO marginally improved the prediction of post-biologic FEV1 increase (adjusted R2: 0.751), compared to BEC (adjusted R2: 0.747) or FeNO alone (adjusted R2: 0.743) (p=0.005 and <0.001, respectively); however, this prediction was not improved by the addition of IgE. Conclusions The ability of higher baseline BEC, FeNO and their combination to predict biologic-associated lung function improvement may encourage earlier intervention in patients with impaired lung function or at risk of accelerated lung function decline.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.002
metaresearch head score (Gemma)0.003
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.002
Threshold uncertainty score0.009

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0020.003
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.001
Bibliometrics0.0010.001
Science and technology studies0.0000.000
Scholarly communication0.0010.000
Open science0.0000.000
Research integrity0.0010.001
Insufficient payload (model declined to judge)0.0010.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.007
GPT teacher head0.243
Teacher spread0.236 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations28
Published2024
Admission routes1
Has abstractyes

Explore more

Same venueFrontiers in ImmunologySame topicAsthma and respiratory diseasesFrench-language works237,207